Zydus Lifesciences Limited — Important, 16-12-2024: General Updates

Zydus Lifesciences Limited's wholly-owned subsidiary, Zydus Animal Health and Investments Limited (ZAHL), has executed a disinvestment of its 6.5% equity stake in Mylab Discovery Solutions Private Limited, originally acquired for Rs. 106 Crore. ZAHL has exercised its Put Option to sell the shares back to Rising Sun Holdings Private Limited (RHSPL) at the same amount. This disinvestment was approved in a board meeting. The termination deed associated with this transaction was also signed on the same day. The expected completion of this sale is within 15 working days following the termination deed signing. While this transaction does not involve related party transactions, it represents a notable financial decision by the company to adjust its investments, reflecting a potential pivot in strategic focus. Investors should monitor the implications of this divestiture for future moves.